Spinal Tech

This is an important year for Zimmer Biomet's pipeline and commercial strategy, according to Zacks Equity Research.

The first spine surgery procedures using MiRus' MoRe superalloy have recently been completed.

The FDA granted Kuros Biosciences approval to evaluate Fibrin-PTH in a Phase 2a clinical trial, reports Seeking Alpha.

Statista released a report projecting the top companies that will have the most orthopedic medical technology market share in 2024. 

Orthopedic surgeon Geoffrey Abrams, MD, joined the scientific advisory board at Endonovo Therapeutics.

Four orthopedic and spine device companies that recently launched or released devices:

The FDA provided 510(k) clearance for 4WEB Medical's Cervical Spine Truss System-Stand Alone interbody fusion device.

Ozop Surgical agreed to an exclusive licensing deal for implants developed by Spinal Resources.

NuVasive appointed NFL hall of famer Jerome Bettis as a brand ambassador.

The FDA approved Eli Lilly's monoclonal antibody Taltz for the treatment of active ankylosing spondylitis in adults, reports Pharmaceutical Business Review.